🚀 VC round data is live in beta, check it out!
Double Medical Technology Valuation Multiples
Discover revenue and EBITDA valuation multiples for Double Medical Technology and similar public comparables like LeMaitre Vascular, Amplifon, Insight Lifetech, GN Store Nord and more.
Double Medical Technology Overview
About Double Medical Technology
Double Medical Technology Inc provides services and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery. It offers product related to Trauma, Spinal and joint. The business activities are carried out through China.
Founded
2004
HQ
Employees
N/A
Website
Financials (FY)
EV
$3B
Double Medical Technology Financials
Double Medical Technology reported last fiscal year revenue of $313M and EBITDA of $82M.
In the same fiscal year, Double Medical Technology generated $215M in gross profit, $82M in EBITDA, and $52M in net income.
Revenue (LTM)
Double Medical Technology P&L
In the most recent fiscal year, Double Medical Technology reported revenue of $313M and EBITDA of $82M.
Double Medical Technology expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $313M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $215M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 69% | XXX | XXX | XXX |
| EBITDA | — | XXX | $82M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 21% | XXX | XXX | XXX |
| Net Profit | — | XXX | $52M | XXX | XXX | XXX |
| Net Margin | — | XXX | 17% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Double Medical Technology Stock Performance
Double Medical Technology has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Double Medical Technology's stock price is $6.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 0.0% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDouble Medical Technology Valuation Multiples
Double Medical Technology trades at 8.0x EV/Revenue multiple, and 30.3x EV/EBITDA.
EV / Revenue (LTM)
Double Medical Technology Financial Valuation Multiples
As of April 20, 2026, Double Medical Technology has market cap of $3B and EV of $3B.
Equity research analysts estimate Double Medical Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Double Medical Technology has a P/E ratio of 50.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 8.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 30.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 38.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 11.6x | XXX | XXX | XXX |
| P/E | — | XXX | 50.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 99.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Double Medical Technology Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Double Medical Technology Margins & Growth Rates
Double Medical Technology's revenue in the last fiscal year grew by 39%.
Double Medical Technology Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 39% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 156% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 28% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 48% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Double Medical Technology Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Double Medical Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| LeMaitre Vascular | XXX | XXX | XXX | XXX | XXX | XXX |
| Amplifon | XXX | XXX | XXX | XXX | XXX | XXX |
| Insight Lifetech | XXX | XXX | XXX | XXX | XXX | XXX |
| GN Store Nord | XXX | XXX | XXX | XXX | XXX | XXX |
| 4DMedical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Double Medical Technology M&A Activity
Double Medical Technology acquired XXX companies to date.
Last acquisition by Double Medical Technology was on XXXXXXXX, XXXXX. Double Medical Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Double Medical Technology
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDouble Medical Technology Investment Activity
Double Medical Technology invested in XXX companies to date.
Double Medical Technology made its latest investment on XXXXXXXX, XXXXX. Double Medical Technology invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Double Medical Technology
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Double Medical Technology
| When was Double Medical Technology founded? | Double Medical Technology was founded in 2004. |
| Where is Double Medical Technology headquartered? | Double Medical Technology is headquartered in China. |
| Is Double Medical Technology publicly listed? | Yes, Double Medical Technology is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Double Medical Technology? | Double Medical Technology trades under 002901 ticker. |
| When did Double Medical Technology go public? | Double Medical Technology went public in 2017. |
| Who are competitors of Double Medical Technology? | Double Medical Technology main competitors are LeMaitre Vascular, Amplifon, Insight Lifetech, GN Store Nord. |
| What is the current market cap of Double Medical Technology? | Double Medical Technology's current market cap is $3B. |
| What is the current revenue of Double Medical Technology? | Double Medical Technology's last fiscal year revenue is $313M. |
| What is the current EV/Revenue multiple of Double Medical Technology? | Current revenue multiple of Double Medical Technology is 8.0x. |
| Is Double Medical Technology profitable? | No, Double Medical Technology is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.